Health IT Analytics June 30, 2022
Researchers have developed an artificial intelligence framework that can successfully identify and differentiate between normal cognition, mild cognitive impairment, Alzheimer’s disease, and non-Alzheimer’s dementias.
A study published in Nature Communications outlines a newly-developed artificial intelligence (AI) framework that can successfully identify and differentiate between normal cognition (NC), mild cognitive impairment (MCI), Alzheimer’s disease (AD), and non-AD dementias (nADD) on par with neurologists and neuroradiologists.
The researchers note that AD is one of the most common causes of dementia worldwide, and that future cases may increase clinical demand past projected capacity of qualified specialists. This potential future lack of neurological specialists, and thus, lack of access to accurate diagnoses for patients with cognitive impairment or dementia, the authors argue, requires...
Today's Sponsors
Today's Sponsor